Bexson Biomedical

Bexson Biomedical

Ketamine and wearable device for post-operative pain.
  • Edit
DateInvestorsAmountRound
-

N/A

-

$4.8m

Series A
Total FundingAUD7.4m

Recent News about Bexson Biomedical

Edit